United-Imaging-Logo

Molecular Imaging

Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
By AuntMinnieEurope.com staff writers
The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.
October 6, 2026
Nuclidium logo featuring blue atomic symbol with red accent and company name in sans-serif type
Mevion to install proton therapy system in Istanbul
By AuntMinnieEurope.com staff writers
The installation will establish the first proton therapy program in Türkiye's private healthcare sector.
September 29, 2026
Turkish flag featuring white crescent moon and star on red background
European Nuclear Medicine Day to tackle access gaps across Europe
By Claudia Tschabuschnig
EANM and Nuclear Medicine Europe will bring policymakers, clinicians, industry, and patients together in Brussels on 29 September to push for more equitable access to nuclear medicine across Europe.
September 25, 2026
Three sagittal PET/CT scan images showing head and neck with metabolic activity heat maps in red, yellow, green, and blue. Brain PET/CT imaging is one of the diagnostic applications of nuclear medicine. nuclear medicine
SPECT/CT holds ground as PET advances cardiac amyloidosis imaging
By Claudia Tschabuschnig
Experts discussed how SPECT/CT remains central to ATTR cardiac amyloidosis diagnosis, while emerging PET tracers could allow more direct imaging of amyloid deposits.
September 22, 2026
Three people in a video conference call displayed in separate windows on a virtual meeting platform
Telix signs agreement to acquire ITM
By Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
Glowing atom symbol with blue and orange neon effects over industrial laboratory equipment
Sustainability in cancer care: from machines to systems
By Claudia Tschabuschnig
Speakers at a session at the IAEA Scientific Forum asked what remains after the machine has been installed.
September 21, 2026
Panel of experts discussing at IAEA Scientific Forum with audience seated at tables
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
By Claudia Tschabuschnig
Research promising one-second treatment planning prompted discussion of workforce shortages and delays in cancer care at the IAEA Scientific Forum in Vienna.
September 17, 2026
Toronto City Hall's iconic curved modernist building with twin towers and international flags under clear blue sky
Radiation medicine aims to tackle cancer care inequalities in low-income countries
By Claudia Tschabuschnig
Health experts discussed challenges facing cancer care in low income countries, the potential of theranostics as well as AI, covering various topics to bridge global health disparities at the IAEA Scientific Forum in Vienna.
September 16, 2026
IAEA Scientific Forum panel discussion with speakers on stage and large display screens showing presenter content
IAEA Scientific Forum: Where you live should not determine access to cancer care
By Claudia Tschabuschnig
At the IAEA Scientific Forum in Vienna, politicians, health policymakers, ministers, and physicians came with a bunch of numbers on the stark differences in access to radiotherapy, nuclear medicine, and medical imaging, especially in low and middle income countries.
September 15, 2026
IAEA logo featuring gold atomic symbol with laurel wreaths and 'Atoms for Peace and Development' text displayed at conference venue
Siemens expands PET detector manufacturing site
By AuntMinnie.com staff writers
The project significantly increases production capacity at its East Tennessee Molecular Imaging Complex.
September 9, 2026
Modern commercial building with American and organizational flags in front parking lot under blue sky
BIR publishes updated IR(ME)R clinical practice guidance
By AuntMinnieEurope.com staff writers
The updated guidance covers responsibilities and includes practical scenarios to support local interpretation and implementation.
September 8, 2026
Clinical Radiology IR(ME)R second edition cover with medical imaging visualization and organizational logos
Q&A with Ken Herrmann: Theranostics must move earlier and beyond established targets
By Claudia Tschabuschnig
Prof. Ken Herrmann discusses the expansion of radioligand therapy into earlier treatment lines, the need for new cancer targets, long-term safety, and the challenge of translating innovation into robust clinical evidence.
September 1, 2026
Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care.Prof. Ken Herrmann, director of the Department of Nuclear Medicine at University Hospital Essen at the opening opening of a new nuclear medicine center in Essen, Germany, focused on theranostics and personalized cancer care. GE Healthcare
Page 1 of 130
Next Page